
Overview
Background
Professor Matt Trau is currently a Professor of Chemistry at The University of Queensland (UQ); and is also Senior Group Leader and co-founder of the Australian Institute for Bioengineering and Nanotechnology. Since graduating from the University of Sydney (BSc Hons I, University Medal) and the University of Melbourne (PhD in Physical Chemistry, 1993), he has held positions in industry and academia across the globe. These include a Fulbright Research Fellowship at Princeton University, USA; and a research scientist at Dow Chemical and ICI Pty Ltd. Professor Trau has been a Visiting Professor at two of the largest Cancer Research Centres in the world: The Dana Farber Cancer Research Institute, Harvard Medical School, Boston (2000); and the Fred Hutchinson Cancer Research Centre, Seattle (2008). Professor Trau is internationally recognised for his innovative and cross-disciplinary research at the interface between chemistry, nanotechnology, biology and medicine. He has co-authored more than 290 refereed publications, many of which appear in the highest impact journals in his field, e.g., fifteen Science and Nature family publications. His major awards and honours include an ARC Laureate Fellowship, an ARC Federation Fellowship (amoungst the most prestigious scientific fellowships in Australia), a Fulbright Research Fellowship to the USA; a Queensland Young Tall Poppy Award; a UQ Foundation/Vice Chancellor’s Research Excellence Award; a Paul Harris Fellowship; and a Pink Circle Award for breast cancer research excellence.
Availability
- Professor Matt Trau is:
- Available for supervision
- Media expert
Fields of research
Qualifications
- Bachelor (Honours) of Science (Advanced), University of Sydney
- Doctor of Philosophy, University of Melbourne
Research impacts
Research
Nanoscience, Nanotechnology, Molecular diagnostics.
Leadership of major multi-disciplinary international programs
Professor Trau has raised more than $22 million in competitive national and international grant funding in the past 10 years. In the last five years, Professor Trau has initiated and led several large international programs that involve close collaboration between leading nanotechnologists, molecular biologists, geneticists and commercial researchers - with the goal of creating cutting edge diagnostics. These include a $4 million National and International Research Alliances Program (NIRAP) grant from the Queensland government ("International Partnership for preventative and Personalised Medicine)"; and two consecutive $5 million multidisciplinary collaborative grants from the National Breast Cancer Foundation (NBCF): "Novel strategies for Prediction and Control of Advanced Breast Cancer via Nanoscaled Epigenetic-Based Biosensors", 2008-2013; and "Enabling Clinical Epigenetic Diagnostics: The Next Generation of Personalized Breast Cancer Care", 2013-2018. These grants involve research collaborations with some of the highest calibre scientists in the world, e.g., Dr Lee Hartwell (2001 Nobel Laureate) from Seattle was a co-chief investigator on the NIRAP grant, and each of the NBCF grants include leading geneticists, pathologists and oncologists from across Australia and around the world. In the past five years, he has been a consultant for a range of national and international companies such as Merck, Digene, Beckman Coulter, Panbio and A.I. Scientific, as well as being the founder and Director of Nanomics BioSystems Pty Ltd (a spinoff company from his laboratory).
Major plenary lectures and international conferences
Since 2003, Professor Trau has presented more than 60 invited plenary/keynote lectures at major international conferences spanning the disciplines of Chemistry, Nanotechnology, Chemical Engineering, Cancer and Diagnostics. Recent examples include: the 4th International NanoBio Conference, (Seattle) 2012; the 14th International Colloid & Surface Science Conference, (Japan) 2012; "Cancer Nanotechnology" Gordon Research Conference, (USA) 2011; the WA Cancer Conference 2011; Sydney Cancer Conference, 2010. In the past 10 years, Professor Trau has played the role of conference convenor, chair, co-chair and symposium chair for 10 major international conferences. Recent examples include: immediate past chair of the 1st International Conference on BioNano Innovation, (Brisbane) 2012; co-chair of the 5th International NanoBio Conference scheduled for Brisbane in 2014.
Works
Search Professor Matt Trau’s works on UQ eSpace
2013
Book Chapter
Detecting DNA methylation for cancer diagnostics and prognostics
Wee, Eugene J. H., Shiddiky, Muhammad J. A. and Trau, Matt (2013). Detecting DNA methylation for cancer diagnostics and prognostics. Microfluidics, nanotechnology and disease biomarkers for personalized medicine applications. (pp. 117-132) edited by Muhammad J. A. Shiddiky, Eugene J. H. Wee, Sakandar Rauf and Matt Trau. New York, NY, United States: Nova Publishers.
2013
Book Chapter
Preface
Shiddiky, Muhammad J.A., Wee, Eugene J.H., Rauf, Sakandar and Trau, Matt (2013). Preface. Microfluidics, nanotechnology and disease biomarkers for personalized medicine applications. edited by Muhammad J. A. Shiddiky, Eugene J. H. Wee, Sakandar Rauf and Matt Trau. Hauppauge, NY, United States: Nova Science Publishers.
2013
Journal Article
"Drill and fill" lithography: fabrication of platinum electrodes and their use in label-free immunosensing
Rauf, Sakandar, Shiddiky, Muhammad J. A., Trau, Matt and Dimitrov, Krassen (2013). "Drill and fill" lithography: fabrication of platinum electrodes and their use in label-free immunosensing. RSC Advances, 3 (13), 4189-4192. doi: 10.1039/c3ra21900c
2013
Conference Publication
Tuneable "nanoshearing": an innovative mechanism for the accurate and specific capture of rare cancer cells
Shiddiky, Muhammad J. A., Vaidyanathan, Ramanathan, Rauf, Sakandar, Tay, Zhikai and Trau, Matt (2013). Tuneable "nanoshearing": an innovative mechanism for the accurate and specific capture of rare cancer cells. μTAS 2013: The 17th International Conference on Miniaturised Systems for Chemistry and Life Sciences (MicroTAS 2013), Freiburg, Germany, 27-31 October, 2013. San Diego, CA, USA: The Chemical and Biological Microsystems Society (CBMS).
2013
Book
Microfluidics, nanotechnology and disease biomarkers for personalized medicine applications
Muhammad J. A. Shiddiky, Eugene J. H. Wee, Sakandar Rauf and Matt Trau eds. (2013). Microfluidics, nanotechnology and disease biomarkers for personalized medicine applications. New Developments in Medical Research, United States: Nova Science Publishers.
2012
Journal Article
eLCR: electrochemical detection of single DNA base changes via ligase chain reaction
Wee, Eugene J. H., Shiddiky, Muhammad J. A., Brown, Melissa A. and Trau, Matt (2012). eLCR: electrochemical detection of single DNA base changes via ligase chain reaction. Chemical Communications, 48 (98), 1214-1216. doi: 10.1039/C2CC35841G
2012
Journal Article
An electrochemical immunosensor to minimize the nonspecific adsorption and to improve sensitivity of protein assays in human serum
Shiddiky, Muhammad J. A., Kithva, Prakash H., Kozak, Darby and Trau, Matt (2012). An electrochemical immunosensor to minimize the nonspecific adsorption and to improve sensitivity of protein assays in human serum. Biosensors and Bioelectronics, 38 (1), 132-137. doi: 10.1016/j.bios.2012.05.014
2012
Journal Article
Tuning particle velocity and measurement sensitivity by changing pore sensor dimensions
Kozak, Darby, Anderson, Will and Trau, Matt (2012). Tuning particle velocity and measurement sensitivity by changing pore sensor dimensions. Chemistry Letters, 41 (10), 1134-1136. doi: 10.1246/cl.2012.1134
2012
Journal Article
Simultaneous size and zet-potential measurements of individual nanoparticles in dispersion using size-tunable pore sensors
Kozak, Darby, Anderson, Will, Vogel, Robert, Chen, Shaun, Antaw, Fiach and Trau, Matt (2012). Simultaneous size and zet-potential measurements of individual nanoparticles in dispersion using size-tunable pore sensors. Acs Nano, 6 (8), 6990-6997. doi: 10.1021/nn3020322
2012
Journal Article
Graphene/quantum dot bionanoconjugates as signal amplifiers in stripping voltammetric detection of EpCAM biomarkers
Shiddiky, Muhammad J. A., Rauf, Sakandar, Kithva, Prakash H. and Trau, Matt (2012). Graphene/quantum dot bionanoconjugates as signal amplifiers in stripping voltammetric detection of EpCAM biomarkers. Biosensors and Bioelectronics, 35 (1), 251-257. doi: 10.1016/j.bios.2012.02.057
2012
Journal Article
Femtomolar detection of a cancer biomarker protein in serum with ultralow background current by anodic stripping voltammetry
Shiddiky, Muhammad J. A., Kithva, Prakash H., Rauf, Sakandar and Trau, Matt (2012). Femtomolar detection of a cancer biomarker protein in serum with ultralow background current by anodic stripping voltammetry. Chemical Communications, 48 (51), 6411-6413. doi: 10.1039/c2cc32810k
2012
Journal Article
Modeling Elastic Pore Sensors for Quantitative Single Particle Sizing
Kozak, Darby, Anderson, Will, Grevett, Matthew and Trau, Matt (2012). Modeling Elastic Pore Sensors for Quantitative Single Particle Sizing. The Journal of Physical Chemistry C: Nanomaterials, Interfaces and Hard Matter, 116 (15), 8554-8561. doi: 10.1021/jp211845t
2012
Edited Outputs
Sensors. Special issue: "Biomarkers and Nanosensors: New Approaches for Biology and Medicine"
Sensors. Special issue: "Biomarkers and Nanosensors: New Approaches for Biology and Medicine". (2012). 12 (SI 7)
2012
Book Chapter
Biosensors for disease biomarker detection
Battersby, B. J., Chen, A., Kozak, D. and Trau, M. (2012). Biosensors for disease biomarker detection. Biosensors for medical applications. (pp. 191-216) edited by Seamus Higson. Oxford, United Kingdom: Woodhead Publishing. doi: 10.1016/B978-1-84569-935-2.50007-3
2011
Journal Article
Advances in resistive pulse sensors: Devices bridging the void between molecular and microscopic detection
Kozak, Darby, Anderson, Will, Vogel, Robert and Trau, Matt (2011). Advances in resistive pulse sensors: Devices bridging the void between molecular and microscopic detection. Nano Today, 6 (5), 531-545. doi: 10.1016/j.nantod.2011.08.012
2011
Journal Article
Sensitive quantification of somatic mutations using molecular inversion probes
Hirani, Rena, Connolly, Ashley R., Putral, Lisa, Dobrovic, Alexander and Trau, Matt (2011). Sensitive quantification of somatic mutations using molecular inversion probes. Analytical Chemistry, Articles ASAP (21), 8215-8221. doi: 10.1021/ac2019409
2011
Journal Article
Multiplatform comparison of multiplexed bead arrays using HPV genotyping as a test case
Corrie, Simon R., Feng, Qinghua, Blair, Tiffany, Hawes, Stephen E., Kiviat, Nancy B. and Trau, Matt (2011). Multiplatform comparison of multiplexed bead arrays using HPV genotyping as a test case. Cytometry Part A, 79A (9), 713-719. doi: 10.1002/cyto.a.21109
2011
Journal Article
Characterisation of amine functionalised poly(3-hydroxybuturate-co-3-hydroxyvalerate) surfaces
Luk, Jing Zhong, Rondeau, Elisabeth, Trau, Matt, Cooper-White, Justin and Grondahl, Lisbeth (2011). Characterisation of amine functionalised poly(3-hydroxybuturate-co-3-hydroxyvalerate) surfaces. Polymer, 52 (15), 3251-3258. doi: 10.1016/j.polymer.2011.05.048
2011
Journal Article
Protein resistance of dextran and dextran-poly(ethylene glycol) copolymer films
Kozak, D, Chen, A, Bax, J and Trau, M (2011). Protein resistance of dextran and dextran-poly(ethylene glycol) copolymer films. Biofouling, 27 (5), 497-503. doi: 10.1080/08927014.2011.584618
2011
Journal Article
Rapid DNA detection by beacon-assisted detection amplification
Connolly, Ashley R and Trau, Matt (2011). Rapid DNA detection by beacon-assisted detection amplification. Nature Protocols, 6 (6), 772-778. doi: 10.1038/nprot.2011.326
Funding
Current funding
Past funding
Supervision
Availability
- Professor Matt Trau is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Multi-Factor Authentication of Extracellular Vesicles in Clinical Settings
Principal Advisor
Other advisors: Dr Richard Lobb, Dr Alain Wuethrich
-
Doctor Philosophy
Utilising extracellular vesicles for the diagnosis of lung cancer.
Principal Advisor
Other advisors: Dr Richard Lobb, Dr Alain Wuethrich
-
Doctor Philosophy
Towards n-plex quantification of molecular interactions for evolution-free biopanning
Principal Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
Single-nanoparticle upconversion nanolasers for probing biological systems
Principal Advisor
-
Doctor Philosophy
Chemical Reactions in Confined Systems
Principal Advisor
Other advisors: Professor Debra Bernhardt
-
Doctor Philosophy
A nano-engineered chip to help manage acute and long-haul COVID-19 patients
Principal Advisor
Other advisors: Dr Alain Wuethrich
-
Doctor Philosophy
Towards n-plex quantification of molecular interactions for evolution-free biopanning
Principal Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
Single-nanoparticle upconversion nanolasers for probing biological systems
Principal Advisor
-
Doctor Philosophy
Digital Nanotechnologies to track molecular aberrations in cancer
Principal Advisor
Other advisors: Dr Richard Lobb, Dr Alain Wuethrich
-
Doctor Philosophy
Single Molecule Readout of Immune Disfunction
Principal Advisor
Other advisors: Dr Richard Lobb, Dr Alain Wuethrich
-
Doctor Philosophy
Utilising extracellular vesicles for the diagnosis of lung cancer.
Principal Advisor
Other advisors: Dr Alain Wuethrich, Dr Richard Lobb
-
Doctor Philosophy
Towards n-plex quantification of molecular interactions for evolution-free biopanning
Principal Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
Investigating therapeutic potentials of brain-derived exosomes
Associate Advisor
Other advisors: Dr Christopher Howard, Dr Richard Lobb
-
Doctor Philosophy
A potential pan-cancer diagnostic utilizing DNA methylation landscapes
Associate Advisor
Other advisors: Dr Abu Sina
-
Doctor Philosophy
The investigation of microglial activation in brain cancer and brain metastasis by an integrated nano-sensor
Associate Advisor
Other advisors: Dr Alain Wuethrich, Dr Richard Lobb
-
Doctor Philosophy
An integrated nano-bioengineered chip for enhanced molecular evolution
Associate Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology
Associate Advisor
Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich
-
Doctor Philosophy
Development of next-generation molecular tools for diagnostics
Associate Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
Advanced Micro and Nano Engineered Sensors for Post Translational Modification based Liquid Biopsy Analysis of Cancer
Associate Advisor
Other advisors: Dr Abu Sina, Dr Alain Wuethrich
-
Doctor Philosophy
Digital nanotechnologies to unravel immune dysregulation in long COVID
Associate Advisor
Other advisors: Dr Alain Wuethrich
-
Doctor Philosophy
Development of next-generation molecular tools for diagnostics
Associate Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
A nano-map of cytokines in skin: Personalising treatment of skin inflammation by a digital nanotechnology
Associate Advisor
Other advisors: Associate Professor Mitchell Stark, Dr Alain Wuethrich
-
Doctor Philosophy
Surface engineering of nanoyeast
Associate Advisor
Other advisors: Dr Christopher Howard
-
Doctor Philosophy
Harnessing nanotechnology to unravel the phenotypic heterogeneity of extracellular vesicles
Associate Advisor
Other advisors: Dr Abu Sina, Associate Professor Mitchell Stark, Dr Alain Wuethrich
-
Doctor Philosophy
Single molecule sensing on nanopillars: Reading complex molecular circuits
Associate Advisor
Other advisors: Dr Alain Wuethrich, Dr Abu Sina
-
Doctor Philosophy
Digital nanotechnologies for profiling trace immune dysregulations and tissue damage in emerging diseases
Associate Advisor
Other advisors: Dr Alain Wuethrich
-
Master Philosophy
Digital catalysis and digital chemistry
Associate Advisor
Other advisors: Dr Shuvashis Dey
-
Doctor Philosophy
A potential pan-cancer diagnostic utilizing DNA methylation landscapes
Associate Advisor
Other advisors: Dr Abu Sina
Completed supervision
-
2024
Doctor Philosophy
Radiopharmaceutical on Demand - Reinventing the Infrastructure of Nuclear Medicine Therapy
Principal Advisor
Other advisors: Dr Shuvashis Dey
-
2024
Doctor Philosophy
Clinical Epigenetics: Technology Development for Biomarkers of Human Health and Diseases
Principal Advisor
Other advisors: Dr Abu Sina, Dr Alain Wuethrich
-
2023
Doctor Philosophy
Bioengineering yeast nanofragment affinity probes for dengue diagnostics
Principal Advisor
Other advisors: Dr Christopher Howard, Dr Alain Wuethrich
-
2023
Doctor Philosophy
Precision Nano-Diagnostics for Dynamically Profiling Glioblastoma Multiforme and the Epithelial-Mesenchymal Transition in Cancer
Principal Advisor
Other advisors: Dr Alain Wuethrich
-
2023
Doctor Philosophy
Novel Nanotechnology Platforms for Cancer Diagnostics
Principal Advisor
Other advisors: Dr Abu Sina
-
2022
Doctor Philosophy
A Bioinformatics Approach Towards an Integrative Multi-Omics Analysis of Pan Cancer Biomarkers
Principal Advisor
-
2021
Doctor Philosophy
Nanoparticle tracking and trapping using computerised feedback control
Principal Advisor
Other advisors: Dr Will Anderson
-
2021
Doctor Philosophy
Driving Nanomaterial-Based Systems towards "Multiomics" Detection for Precision Oncology
Principal Advisor
-
2021
Doctor Philosophy
Two Photon Laser Techniques for 3D Miniaturized Structures: Resistive-pulse Sensing and Potential Bio-uses
Principal Advisor
Other advisors: Dr Alain Wuethrich
-
2021
Doctor Philosophy
Probing cancer epigenetics with highly multiplexed PCR and targeted resequencing
Principal Advisor
-
2020
Doctor Philosophy
Engineering Surface-Enhanced Raman Scattering Strategies for Liquid Biopsy Analyses: A Step Towards Precision Medicine in Cancer Management
Principal Advisor
-
2020
Doctor Philosophy
Extracellular Vesicles as Circulating Breast Cancer Biomarkers
Principal Advisor
-
2020
Doctor Philosophy
SERS-Microfluidic Assay for Rapid Profiling of Cancer Biomarkers
Principal Advisor
-
2019
Doctor Philosophy
Unravelling pathologic protein phosphorylation with interfacial biosensing: a new approach for cancer detection and therapy monitoring
Principal Advisor
-
2019
Doctor Philosophy
Point-of-care tuberculosis diagnostics: Meeting global needs through innovative nanotechnologies
Principal Advisor
Other advisors: Professor Nick West
-
2019
Doctor Philosophy
Miniaturized Techniques for Rare Cell Isolation, Release and Molecular Analysis
Principal Advisor
-
2018
Doctor Philosophy
Advancing Gene Fusion Detection towards Personalized Cancer Nanodiagnostics
Principal Advisor
-
2017
Doctor Philosophy
Detecting DNA methylation at the gold interface: A gateway towards next generation cancer diagnostics
Principal Advisor
-
2017
Master Philosophy
Bioinformatic Tools and Applications for Analysis of DNA Methylation
Principal Advisor
-
2016
Doctor Philosophy
Resistive pulse sensing through tunable nano-scale devices: Fundamental investigations, developments and applications
Principal Advisor
-
2015
Doctor Philosophy
Nanoyeast Antibody Fragments: Engineering the Next Generation of Molecular Diagnostics
Principal Advisor
-
2014
Doctor Philosophy
Towards comprehensive DNA methylation analysis using molecular inversion probes
Principal Advisor
-
2010
Doctor Philosophy
Development of a Multiplexed Particle-based Immunoassay for Biomarker Screening
Principal Advisor
-
2008
Doctor Philosophy
Dual Purpose Colloids for Peptide Synthesis and Bio-Assay Applications
Principal Advisor
Other advisors: Professor Gwendolyn Lawrie
-
2007
Doctor Philosophy
DEVEOPMENT A LOAD-BEARING NANOCOMPOSITE BIODEGRADABLE SCAFFOLD FOR USE IN BONE TISSUE ENGINEERING
Principal Advisor
Other advisors: Professor Lisbeth Grondahl
-
2007
Doctor Philosophy
ENCODING MICROSPHERE-BASED LIBRARIES USING FLOW CYTOMETRY: A SCALABLE METHOD FOR DIRECTED COMBINATORIAL SYNTHESIS
Principal Advisor
Other advisors: Professor Gwendolyn Lawrie
-
2006
Doctor Philosophy
PREPARATION OF NOVEL MATERIALS FOR RAPID DNA SEQUENCING
Principal Advisor
Other advisors: Professor Gwendolyn Lawrie
-
2006
Doctor Philosophy
DEVELOPMENT OF MULTIPLEXED PARTICLE ASSAYS FOR DNA SCREENING APPLICATIONS
Principal Advisor
Other advisors: Professor Gwendolyn Lawrie
-
2003
Doctor Philosophy
NANOSTRUCTURED BIOMATERIALS AND DEVICES
Principal Advisor
Other advisors: Professor Halina Rubinsztein-Dunlop
-
2024
Doctor Philosophy
Advanced Micro and Nano Engineered Sensors for Post Translational Modification based Liquid Biopsy Analysis of Cancer
Associate Advisor
Other advisors: Dr Abu Sina, Dr Alain Wuethrich
-
2016
Doctor Philosophy
Development of point-of-care and multiplex diagnostic methods for the detection of plant pathogens
Associate Advisor
Other advisors: Professor Jimmy Botella
-
2015
Doctor Philosophy
Nanoshearing: A Microfluidic Approach for Isolation and Enumeration of Cancer Biomarkers
Joint Principal Advisor
-
2012
Doctor Philosophy
Detection and quantification of miRNA promoter DNA methylation as prognostic biomarkers for breast cancer
Associate Advisor
Other advisors: Professor Melissa Brown
-
2010
Doctor Philosophy
Understanding effects of nanoparticle dispersion on physical and mechanical properties of HA/PHBV nanocomposites
Associate Advisor
Other advisors: Professor Darren Martin
-
2008
Doctor Philosophy
Self Assembled Nano-coats for Protection of Foreign Tissue Transplants
Associate Advisor
Other advisors: Professor Lars Nielsen
-
2007
Doctor Philosophy
IN VITRO AND IN VIVO CHARACTERIZATION OF CELLULAR RESPONSES TO PHBV AND HYDROXYAPATITE/PHBV COMPOSITES AS BONE BIOMATERIALS
Associate Advisor
Other advisors: Professor Lisbeth Grondahl
Media
Enquiries
Contact Professor Matt Trau directly for media enquiries about:
- Biomarkers
- Biosensors
- Breast cancer
- Cancer
- Colloid science
- Diagnostics cancer
- Materials science
- Medicine - personalised
- Nanobiotechnology
- Nanotechnology
- Personalised medicine
- Physical Chemistry
- Preventative medicine
- Surface science
Need help?
For help with finding experts, story ideas and media enquiries, contact our Media team: